Can I stop taking GLP-1 medications once I reach my goal
GLP-1 agonists, widely used to treat type 2 diabetes and manage obesity, were associated with a lower risk of metastatic progression of certain obesity-related cancers, in particular lung, breast, colorectal and liver cancer, according to study results presented at a media briefing in advance of the upcoming American Society of Clinical Oncology Annual Meeting (ASCO 2026)
Levotiroxina : la semaglutida puede aumentar la concentracin sangunea de levotiroxina
While its challenging to do both simultaneously, its not impossible
PlexusDx patients interested in optimizing their response can explore the Precision Peptide Genetic Test, which maps 14 pathways and 49 peptides to reveal individual variations in GLP-1 receptor sensitivity and related metabolic factors
GLP-1 medications are usually started at low doses